Results 261 to 270 of about 25,658,089 (295)
Some of the next articles are maybe not open access.
Expert Opinion on Therapeutic Targets, 2008
Topoisomerase I is required for DNA relaxation during critical cellular functions. The identification of camptothecins as specific enzyme inhibitors and their clinical efficacy have stimulated extensive efforts to exploit topoisomerase I as a tumor target and explain the putative mechanisms of antitumor-specific action.This review provides an overview ...
Giovanni Luca, Beretta +2 more
openaire +2 more sources
Topoisomerase I is required for DNA relaxation during critical cellular functions. The identification of camptothecins as specific enzyme inhibitors and their clinical efficacy have stimulated extensive efforts to exploit topoisomerase I as a tumor target and explain the putative mechanisms of antitumor-specific action.This review provides an overview ...
Giovanni Luca, Beretta +2 more
openaire +2 more sources
Inhibitors of Topoisomerase I Function
2005As noted elsewhere in this book, the locus of action of camptothecin (CPT) (1) (Fig. 1) as an antitumor agent involves the noncovalent binding of this agent to the covalent binary complex formed between topoisomerase I (TOP-I) and DNA (Fig. 2) (1). Although the equilibrium between free enzyme and the enzyme-DNA binary complex normally lies far toward ...
openaire +1 more source
DNA Topoisomerase I Inhibitors from Rinorea anguifera.
ChemInform, 2005AbstractFor Abstract see ChemInform Abstract in Full Text.
Ji, Ma +4 more
openaire +2 more sources
Topoisomerase I inhibitors: topotecan and irenotecan
Cancer Treatment Reviews, 1994G J, Creemers, B, Lund, J, Verweij
openaire +2 more sources
Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors.
Pharmacy world & science : PWS, 1998In this review the clinical pharmacokinetics of camptothecin topoisomerase I inhibitors, an important new class of anticancer drugs, is discussed. Two prototypes, topotecan and irinotecan, are currently marketed in many European countries and the USA for the treatment of patients with ovarian and colorectal cancer, respectively.
Herben, V.M.M. +3 more
openaire +2 more sources
[Molecular determinants of response to topoisomerase I inhibitors].
Bulletin du cancer, 2011Nuclear topoisomerase I (Top1) is involved in the relaxation of DNA supercoiling and plays a pivotal role in the coordination of essential DNA processes such as transcription, replication, DNA recombination and DNA damage signalling. For all these reasons, Top1 has been an attractive target for the development of anticancer drugs, which poison Top1 by ...
Pourquier, Philippe, Lansiaux, Amélie
openaire +4 more sources
A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
International Journal of Molecular Sciences, 2023Toluwase Hezekiah Fatoki
exaly

